FAKTOR-XIIA-INHIBITOREN

European patent · EP3788039 · In force

Register entry

Publication number: EP3788039
Application number: EP19721369
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Apr 29, 2019
Published: Mar 10, 2021
Granted: Feb 11, 2026
Protection ends at the latest: Apr 28, 2039
Next annual fee due: Apr 30, 2027
IPC classes: C07D 403/12 (2006.01)
C07D 401/14 (2006.01)
C07D 401/12 (2006.01)
C07D 403/14 (2006.01)
C07D 405/12 (2006.01)
C07D 241/04 (2006.01)
C07D 471/04 (2006.01)
C07D 211/14 (2006.01)
A61P 7/02 (2006.01)
A61K 31/496 (2006.01)
Priority: GB 201807014 30.04.2018
PCT application: PCT/GB2019/051180 29.04.2019
PCT publication: WO2019/211585 07.11.2019
Filing language: English
Source: Swissreg

What the Federal Institute of Intellectual Property published about this title, newest first.

Jul 1, 2026
Change
Published in Swissreg on 01.07.2026
May 1, 2026
Next annual fee due on
Next annual fee due on
30.04.2026 → 30.04.2027
Published in Swissreg on 01.05.2026
Feb 13, 2026
Agent entered
Representative
HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel
Published in Swissreg on 13.02.2026
Feb 11, 2026
Granted
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 11.02.2026

Leeds LS2 9JT, GB

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

PHILIPPOU, Helen

Leeds LS2 9JT, GB

FOSTER, Richard

Leeds LS2 9JT, GB

FISHWICK, Colin

Leeds LS2 9JT, GB

REVILL, Charlotte

Leeds LS2 9JT, GB

YULE, Ian

Leeds LS2 3AA, GB

TAYLOR, Roger

Leeds LS2 3AA, GB

NAYLOR, Alan

Cambridgeshire CB22 7QJ, GB

FALLON, Philip Spencer